Creatine reduces oxidative stress markers but does not protect against seizure susceptibility after severe traumatic brain injury

Brain Research Bulletin

Volumn 87, Issue 2-3, 2012, Pages 180-186

  Saraiva, André Luis Lopes ^a   Ferreira, Ana Paula Oliveira ^a   Silva, Luiz Fernando Almeida ^a   Hoffmann, Maurício Scopel ^a   Dutra, Fabrício Diniz ^a   Furian, Ana Flavia ^a   Oliveira, Mauro Schneider ^a   Fighera, Michele Rechia ^a   Royes, Luiz Fernando Freire ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Carbonyl; Creatine; Na +,K + ATPase; Post traumatic epilepsy; TBARS; Traumatic brain injury

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARBONYL DERIVATIVE; CREATININE; PENTETRAZOLE; PROTEIN; PROTEIN CARBONYL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN LEVEL; CLONIC SEIZURE; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; ENZYME INHIBITION; GRAND MAL SEIZURE; LATENT PERIOD; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT; SEIZURE SUSCEPTIBILITY; TONIC CLONIC SEIZURE; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CREATINE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPSY, POST-TRAUMATIC; MALE; OXIDATIVE STRESS; PENTYLENETETRAZOLE; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84856591956     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.10.010     Document Type: Article

References (46)

1. Adhihetty P.J., Beal M.F. Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. Neuromol. Med. 2008, 10:275-290.
2. Andres R.H., Ducray A.D., Schlattner U., Wallimann T., Widmer H.R. Functions and effects of creatine in the central nervous system. Brain Res. Bull. 2008, 76:329-343.
3. Ansari M.A., Roberts K.N., Scheff S.W. A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI. J. Neurotrauma 2008, 25(5):513-526.
4. +-ATPase motion and incorporation into the plasma membrane in response to G protein-coupled receptor signals in living cells. Mol. Biol. Cell 2003, 14:1149-1157.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 1976, 72:248-254.
6. +-ATPase. J. Physiol. 1999, 518:37-46.
7. D'Ambrosio R., Fairbanks J.P., Fender J.S., Born D.E., Doyle D.L., Miller J.W. Post-traumatic epilepsy following fluid percussion injury in the rat. Brain 2004, 127:304-314.
8. Ferraro T.N., Golden G.T., Smith G.G., StJean P., Schork N.J., Mulholland N., Ballas C., Schill J., Buono R.J., Berrettini W.H. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J. Neurosci. 1999, 19:6733-6739.
9. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 1925, 66:375-400.
10. Frey L.C. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 2003, 44:11-17.
11. Furian A.F., Fighera M.R., Oliveira M.S., Ferreira A.P., Fiorenza N.G., de Carvalho J.M., Petry J.C., Coelho R.C., Mello C.F., Royes L.F. Methylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum. Neurochem. Int. 2007, 50(1):164-171.
12. Garga N., Lowenstein D.H. Posttraumatic epilepsy: a major problem in desperate need of a major advances. Epilepsy Curr. 2006, 6:1-5.
13. Glaser V., Leipnitz G., Straliotto M.R., Oliveira J., dos Santos V.V., Wannmacher C.M., de Bem A.F., Rocha J.B., Farina M., Latini A. Oxidative stress-mediated inhibition of brain creatine kinase activity by methylmercury. Neurotoxicology 2010, 31(5):454-460.
14. Golarai G., Greenwood A.C., Feeney D.M., Connor J.A. Physiological and structural evidence for hippocampal involvement in persistent seizure susceptibility after traumatic brain injury. J. Neurosci. 2001, 21(21):8523-8537.
15. Graber K.D., Prince D.A. A critical period for prevention of neocortical post-traumatic epileptogenesis in rats. Ann. Neurol. 2004, 55:860-870.
16. Gurkoff G.G., Giza C.C., Shin D., Auvin S., Sankar R., Hovda D.A. Acute neuroprotection to pilocarpine-induced seizures is not sustained after traumatic brain injury in the developing rat. Neuroscience 2009, 164(2):862-876.
17. Kharatishvili I., Pitkänen A. Posttraumatic epilepsy. Curr. Opin. Neurol. 2010, 23(2):183-188.
18. Kharatishvili I., Immonen R., Gröhn O., Pitkänen A. Quantitative diffusion MRI of hippocampus as a surrogate marker for post-traumatic epileptogenesis. Brain 2007, 130(Pt 12):3155-3168.
19. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186:464-478.
20. +-ATPase activity impairment after experimental traumatic brain injury: relationship to spatial learning deficits and oxidative stress. Behav. Brain Res. 2008, 193:306-310.
21. +-ATPase inhibition after traumatic brain injury. Brain Res. 2009, 1279:147-155.
22. Longhi L., Saatman K.E., Fujimoto S., Raghupathi R., Meaney D.F., Davis J., McMillan B.S.A., Conte V., Laurer H.L., Stein S., Stocchetti N., McIntosh T.K. Temporal window of vulnerability to repetitive experimental concussive brain injury. Neurosurgery 2005, 56(2):364-374.
23. Löscher W., Hönack D., Fassbender C.P., Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. pentylenetetrazole seizure models. Epilepsy Res. 1991, 8:171-189.
24. Maas A.I., Roozenbeek B., Manley G.T. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 2010, 7(1):115-126.
25. Maciejak P., Szyndler J., Turzyńska D., Sobolewska A., Bidziński A., Kołosowska K., Płaźnik A. Time course of changes in the concentrations of amino acids in the brain structures of pentylenetetrazole-kindled rats. Brain Res. 2010, 1342:150-159.
26. Magni D.V., Oliveira M.S., Furian A.F., Fiorenza N.G., Fighera M.R., Ferreira J., Mello C.F., Royes L.F. Creatine decreases convulsions and neurochemical alterations induced by glutaric acid in rats. Brain Res. 2007, 1185:336-345.
27. McColl C.D., Horne M.K., Finkelstein D.I., Wong J.Y., Berkovic S.F., Drago J. Electroencephalographic characterization of pentylenetetrazole-induced seizures in mice lacking the α4 subunit of the neuronal nicotinic receptor. Neuropharmacology 2003, 44:234-243.
28. McIntosh T.K., Vink R., Noble L., Yamakami I., Fernyak S., Soares H., Faden A.L. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 1989, 28(1):233-244.
29. McKinney R.A., Debanne D., Gähwiler B.H., Thompson S.M. Lesion-induced axonal sprouting and hyperexcitability in the hippocampus in vitro: implications for the genesis of posttraumatic epilepsy. Nat. Med. 1997, 3:990-996.
30. +-ATPase in rat striatal synaptosomes. Neurochem. Int. 1998, 33:531-540.
31. Mujika I., Padilla S. Creatine supplementation as an ergogenic acid for sports performance in highly trained athletes: a critical review. Int. J. Sports Med. 1997, 18:491-496.
32. +-ATPase isoforms in rat neostriatum by dopamine and protein kinase C. J. Neurochem. 1999, 73:1492-1501.
33. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
34. Oliveira M.S., Furian A.F., Royes L.F.F., Fighera M.R., Myskiw J.C., Fiorenza N., Mello C.F. Ascorbate modulates pentylenetetrazol-induced convulsions biphasically. Neuroscience 2004, 128:721-728.
35. Opii W.O., Nukala V.N., Sultana R., Pandya J.D., Day K.M., Merchant M.L., Klein J.B., Sullivan P.G., Butterfield D.A. Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. J. Neurotrauma 2009, 24:772-779.
36. Pitkänen A., Lukasiuk K. Molecular and cellular basis of epilepstogenesis in symptomatic epilepsy. Epilepsy Behav. 2009, 14:16-25.
37. Pitkänen A., McIntosh Animal models of post-traumatic epilepsy. J. Neurotrauma 2006, 26:241-261.
38. Rambo L.M., Ribeiro L.R., Oliveira M.S., Furian A.F., Lima F.D., Souza M.A., Silva L.F., Retamoso L.T., Corte C.L., Puntel G.O., de Avila D.S., Soares F.A., Fighera M.R., Mello C.F., Royes L.F. Additive anticonvulsant effects of creatine supplementation and physical exercise against pentylenetetrazol-induced seizures. Neurochem. Int. 2009, 55:333-340.
39. Sakellaris G., Kotsiou M., Tamiolaki M., Kalostos G., Tsapaki E., Spanaki M., Spilioti M., Charissis G., Evangeliou A. Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study. J. Trauma 2006, 61:322-329.
40. Scheff S.W., Dhillon H.S. Creatine-enhanced diet alters levels of lactate and free fatty acids after experimental brain injury. Neurochem. Res. 2004, 29:469-479.
41. Silva L.F., Hoffmann M.S., Rambo L.M., Ribeiro L.R., Lima F.D., Furian A.F., Oliveira M.S., Fighera M.R., Royes L.F. The involvement of Na(+),K(+)-ATPase activity and free radical generation in the susceptibility to pentylenetetrazol-induced seizures after experimental traumatic brain injury. J. Neurol. Sci. 2011, 308(1-2):35-40.
42. Sullivan P.G., Geiger J.D., Mattson M.P., Scheff S.W. Dietary supplement creatine protects against traumatic brain injury. Ann. Neurol. 2000, 48:723-729.
43. Wallimann T., Tokarska-Schlattner M., Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids 2011, 40(5):1271-1296.
44. Wu A., Ying Z., Gomez-Pinilla F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp. Neurol. 2006, 197:309-317.
45. +-ATPase activity in cerebral cortex of rats. Neuroreport 2000, 11:2331-2334.
46. Yan L.J., Traber M.G., Packer L. Spectrophotometric method for determination of carbonyls in oxidatively modified apolipoprotein B of human low-density lipoproteins. Anal. Biochem. 1995, 228:349-351.